These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 19068402

  • 1. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
    Lassmann H.
    Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
    [Abstract] [Full Text] [Related]

  • 2. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H, Geurts JJ.
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [Abstract] [Full Text] [Related]

  • 3. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [Abstract] [Full Text] [Related]

  • 4. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.
    De Keyser J, Steen C, Mostert JP, Koch MW.
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1645-51. PubMed ID: 18594554
    [Abstract] [Full Text] [Related]

  • 5. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [Abstract] [Full Text] [Related]

  • 6. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
    Vos CM, Geurts JJ, Montagne L, van Haastert ES, Bö L, van der Valk P, Barkhof F, de Vries HE.
    Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
    [Abstract] [Full Text] [Related]

  • 7. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 8. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, Tribolo A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [Abstract] [Full Text] [Related]

  • 9. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D, Miller D.
    J Neurol Sci; 2009 Jul 15; 282(1-2):5-11. PubMed ID: 19201002
    [Abstract] [Full Text] [Related]

  • 10. Visualizing the cause of gray matter atrophy in multiple sclerosis.
    Richert ND, Kraft E, Stüve O.
    Arch Neurol; 2009 Feb 15; 66(2):159-60. PubMed ID: 19204151
    [No Abstract] [Full Text] [Related]

  • 11. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M, Agosta F.
    Prog Brain Res; 2009 Feb 15; 175():465-82. PubMed ID: 19660674
    [Abstract] [Full Text] [Related]

  • 12. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H.
    Brain; 2005 Nov 15; 128(Pt 11):2705-12. PubMed ID: 16230320
    [Abstract] [Full Text] [Related]

  • 13. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
    Rausch M, Tofts P, Lervik P, Walmsley A, Mir A, Schubart A, Seabrook T.
    Mult Scler; 2009 Jan 15; 15(1):16-27. PubMed ID: 18971220
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS.
    Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1128-33. PubMed ID: 18287567
    [Abstract] [Full Text] [Related]

  • 16. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R, Sepcić J.
    Lijec Vjesn; 2006 Mar 25; 128(9-10):295-308. PubMed ID: 17128669
    [Abstract] [Full Text] [Related]

  • 17. [Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis].
    Harting I, Sellner J, Meyding-Lamadé U, Sartor K.
    Rofo; 2003 May 25; 175(5):613-22. PubMed ID: 12743852
    [Abstract] [Full Text] [Related]

  • 18. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A.
    Neurologia; 2000 May 25; 15(7):288-302. PubMed ID: 11075577
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.